Sara Sarkey, PhD, is affiliated with Takeda Pharmaceuticals USA, Inc. in Lexington, Massachusetts. Sarkey has published research focusing on Attention-Deficit/Hyperactivity Disorder in both children, adolescents, and adults, with particular attention to the impact of the COVID-19 pandemic on patient and caregiver experiences. Contributions include studies exploring management challenges during the pandemic, as featured in Psychiatrist.com from 2023 to 2024.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
